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Abstract
In the developed world, the trend toward women of advanced age bearing children is very prevalent and seems likely to continue . 
For a variety of reasons, women are delaying pregnancy until 35 years and older when they suddenly seem keenly aware that their 
biological clocks are ticking . A review of various studies obtained from the Proquest and EBSCO databases indicates that there are 
definitely certain risks associated with advanced maternal age (AMA). As females age, the reduced number and quality of their re-
maining eggs contribute to reduced fertility . Congenital anomalies involving the number of chromosomes in the embryo increases as 
well . The risk of miscarriage gradually climbs with the mother’s age and stillbirth is more likely than in younger women . The health of 
the older women prior to pregnancy is often compromised and birth-related complications are more common . Studies of mice have 
shown that maternal age influences the structure and functionality of the uterus. It has been suggested that delayed childbearing 
has an effect on the gene frequency in the general population since the zygotes best able to adapt to the Advanced Maternal Age 
(AMA) uterine environment were favored (Gloria-Bottini et al ., 2005) . Although women who postpone parenthood should take the 
increased risks into account, findings suggest that maternal age, per se, should not be a deterring factor when considering bearing 
a child . Individual health circumstances and behavioral choices are more important than age . With proper prenatal counselling and 
care, AMA women can hope to have normal pregnancies and deliver healthy babies . 
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Introduction
Advanced maternal age is defined as pregnancy in women 
equal to or greater than thirty-five years of age. It is be-
coming a growing trend, especially in high-income coun-
tries, to delay childbearing. Pregnancy in AMA mothers 
constitute 20% of pregnancies in the UK and 16% of 
pregnancies in the US as of 2014. Many women marry 
later, spend a decade or more building up their careers, 
pursue higher education, or enjoy the single life before 
deciding to have a family. Others may find themselves hav-
ing their first child in their thirties because of previous 
fertility complications. Although better socio-economic 
conditions and developments in assisted reproductive 
technology are allowing women to have babies later in 
life, this new trend can possibly present clinical risks both 
to the mother and baby (Lean et al., 2017a).
Prenatal concerns for AMA mothers include fetal 
loss, chromosome anomalies such as Down’s Syndrome, 
multiple births, hypertension, and gestational diabetes. 
Complications in labor and delivery might include placen-
ta previa (when the placenta covers the opening in the 
cervix), caesarean birth, preterm birth, placental abrup-
tion (when the placenta detaches from the womb), low 
birth weight, trisomies, and other non-disjunction prob-
lems. Abnormal functioning of the placenta, due to aging, 
can result in fetal growth restriction and even stillbirths 
(Radhakrishnan, 2016).
It is important to point out that women who are preg-
nant and are older than 35 have some distinct advantag-
es. They are more likely to follow the regimen outlined 
for them by their obstetrician, such as taking a folic acid 
supplement before conception and throughout their first 
trimester which helps decrease the risk of neural tube 
defects. These mothers are more likely to be diligent 
about keeping prenatal appointments. They are usually 
more established in their personal and professional lives 
and are more mature and knowledgeable, with a higher 
degree of personal control and coping strategies. Their 
higher income tends to contribute to more positive re-
sults in terms of their health. Lastly, AMA mothers tend 
to breastfeed more than younger mothers. Breastfeeding 
is considered the most optimal way to feed the infant. 
Its benefits include protecting the baby with passive im-
munity to infections of the respiratory and gastrointes-
tinal tracts. Breastfeeding has maternal benefits as well; 
it reduces postpartum bleeding, returns the mother to 
pre-pregnancy weight faster, and decreases the risk of 
breast and ovarian cancers (Radhakrishnan, 2016).
Notwithstanding all of the above advantages, the ideal 
time for a woman to give birth remains up until the age of 
35, during which time fertility is at its peak. Women who 
are older have a harder time conceiving. They usually also 
have longer work hours and stressful work environments 
and tend to drink more alcohol, putting the fetus at risk 
of Fetal Alcohol Spectrum Disorder, which can cause 
birth defects and neuro-developmental disorders. They 
have also been exposed to environmental toxins for a 
longer time. Most importantly though, their increased age 
makes medical conditions such as cancer, diabetes, hyper-
tension, and arthritis more likely. These conditions, as well 
as their associated treatments and medications, can harm 
the fetus (Radhakrishnan, 2016). 
Many studies have been done in various developed 
countries, investigating the impact AMA has on perinatal 
and neonatal outcomes in these women. These studies 
are important for both the mothers and the healthcare 
providers. The effects of AMA on maternal and fetal mor-
bidity and mortality is of great concern.
Methods
The research was obtained from the online Touro College 
Library. Articles were collected from the Proquest and 
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EBSCO databases. The studies presented a comprehen-
sive analysis of the topic and allowed for a conclusion to 
be reached regarding the research question.
Discussion
A systematic review and meta-analysis were done to de-
termine the risk of stillbirth and other negative pregnan-
cy outcomes in AMA women. It was the largest and most 
comprehensive review investigating pregnancy outcomes 
of AMA mothers and the only one specifically focusing 
on the increased risk of stillbirth. The studies in the re-
view were significant considering that in 2013 the rate of 
births in England and Wales to women of 35 years and 
above was 20% as compared to a rate of 6% in 1980 
(Lean et al., 2017a).
In the review, 63 cohort studies and 12 case control 
studies were included. The studies incorporated control 
groups of mothers younger than 35 years of age and AMA 
groups greater than or equal to 35 years. Primary out-
comes studied were stillbirth and fetal growth restric-
tion. Secondary outcomes were neonatal death, small 
for gestational age, neonatal intensive care unit (NICU) 
admissions, preeclampsia (blood pressure > 140/90 with 
significant amount of protein in the urine), placental 
abruption, preterm birth, and gestational diabetes melli-
tus. Studies that involved pregnancies of multiple fetuses 
or those that focused on chromosomal abnormalities or 
substance abuse were eliminated. Correlations between 
stillbirth rates and maternal obesity, diabetes, hyperten-
sion, and assisted reproductive therapies were recorded 
(Lean et al., 2017a).
AMA was found to increase the rate of stillbirth in the 
population to 4.7%. In addition, AMA increased the risk 
of fetal growth restriction, neonatal death, NICU admis-
sion and gestational diabetes mellitus. The relationship 
between AMA and stillbirth was not found to be asso-
ciated with maternal morbidities, with the exception of 
hypertension which was positively correlated with AMA 
in women between the ages of 35 and 40. The use of 
assisted reproductive therapy (ART) showed no relation-
ship to stillbirths in women equal to or under 35 years 
of age and was negatively correlated to stillbirth rates in 
women over 40. AMA only significantly increased the risk 
of fetal growth restriction in women over 40. The major-
ity of secondary outcomes were more prevalent in AMA 
women but only NICU admissions and neonatal deaths 
had a substantial correlation to the increasing age of the 
mother (Lean et al., 2017a).
Stillbirths in advanced countries are presently thought 
to be related to placental dysfunctions. Accelerated aging 
of the placenta, altered vascular function and altered 
transport of nutrients compared to a control group have 
all been detected. Another theory for the cause of still-
births is the diminished genetic quality of the aging oo-
cyte (Lean et al., 2017a).
Another consideration that may contribute to fetal 
health with an AMA pregnancy is advanced paternal age. 
Research in this area is sparse. One study found a 24% in-
crease in stillbirth rate with paternal age between 40-45 
years old and a 50% increase with paternal age over 45, 
independent of maternal age. More studies are needed 
where paternal age is a co-variate to determine how it 
contributes to increased risk of stillbirth in AMA mothers 
(Lean et al., 2017a).
Future studies should be done to understand the mech-
anisms contributing to the increased risk of stillbirth in 
AMA, specifically in mothers over the age of 40, so that 
proper intervention can be applied to improve positive 
outcomes to those at greatest risk (Lean et al., 2017a).
The increased risks of fetal growth restriction and 
stillbirths in AMA mothers have been found to be inde-
pendent of co-morbidities. These risks also do not seem 
to correlate with factors such as socio-economic status, 
nutritional supplementation prior to conception, good 
prenatal care, and the mothers being non-smokers. A hy-
pothesis was offered that maternal aging was associated 
with utero-placental dysfunction which contributed to 
negative fetal outcomes (Lean et al., 2017b).  
Dysfunction of the placenta is a major cause of fetal 
growth restriction and placental causes are noted in up 
to 65% of stillbirths. In both conditions, major changes 
in placental morphology were found, including lower 
placental weight, irregular shape to the placenta, and 
irregular insertion of the umbilical cord. Placentas from 
fetal growth restriction pregnancies had less vascular 
branching and fewer capillaries. These structural abnor-
malities were found even more in stillbirths related to 
fetal growth restriction (Lean et al., 2017b).  
Abnormal function of the placenta was also apparent 
in fetal growth restriction and stillbirths. Among these 
were reduced amino acid transport in the placenta and 
impaired endocrine function (Lean et al., 2017b).  
A study was done to test the hypothesis that AMA is 
associated with dysfunctions of the uterus and placenta. 
Women of AMA were studied along with young controls 
(20-30 years) with normal pregnancies.  Investigations 
into these pregnancies identified multiple placental and 
utero-placental dysfunctions, potentially linking those 
mechanisms and increased fetal growth restriction and 
stillbirths in AMA women (Lean et al., 2017b).  
The studies revealed increased placental weight but re-
duced placental efficiency in pregnancies of AMA women 
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with changes in placental morphology and function simi-
lar to the phenotype of placentas in fetal growth restric-
tion and stillborn pregnancies. This phenotype was seen 
even in normal pregnancy outcomes which indicate both 
the negative effects of aging on the placenta and potential 
adaptation to achieve a normal birthweight. The abnormal 
placental phenotype was more evident in women >40 
years of age who have a higher risk of adverse pregnancy 
outcomes (Lean et al., 2017b).  
AMA mice displayed an even more exaggerated abnor-
mality in placental phenotype than humans, with reduced 
number of offspring, late fetal deaths, and over half of off-
spring in the category of fetal growth restriction. Many 
similarities were found in the placental phenotype in the 
mice and human pregnancy models, including increased 
placental weight, decreased placental efficiency, and al-
tered vascular function (Lean et al., 2017b).  
All of these support the hypothesis that maternal aging 
is associated with placental dysfunction, which may result 
in higher rates of fetal growth restriction and stillbirths 
in AMA pregnancies. Abnormal cell turnover, abnormal 
nutrient transport, and increased relaxation of placen-
tal arteries all helped contribute to the less than ideal 
functioning of the placenta in AMA mothers (Lean et al., 
2017b).  
Another study was done to determine whether ad-
vanced maternal age in mice has a bearing on their 
pregnancy outcomes. The purpose of this study was to 
evaluate whether negative reproductive outcomes in 
aged female mice are a result of a dysregulation of meth-
ylation, and thus expression, of imprinted genes in their 
reproductive tissues. Tissues from the fetus, placenta, and 
ovaries were collected from young pregnant mice (4-5 
weeks old) and aged mice (15 months old) and compared 
to matured oocyte and uterine tissue from non-pregnant 
ones (Paczkowski et al., 2015).  
Results showed fetal growth restriction and over-
growth of the placenta in the older pregnant mice. 
Placental tissue showed aberration in methylation and 
transcript abundance of imprinted genes. Methylation and 
gene expression were severely dysregulated in the ova-
ries and in the uterus, including nutrient transport genes. 
There was also increased transcript abundance in oo-
cytes obtained from older females, compared to younger 
ones (Paczkowski et al., 2015). 
Major alterations in methylation and gene expression 
in the older ovary suggests that the environment in the 
follicle may not be optimal. This affects oocyte growth 
and quality, leading to compromised embryonic and fetal 
development. Aberrant methylation and expression of im-
printed genes in the uterus obtained from aged mice may 
cause reduced implantation. Even though AMA mothers 
have an equal chance of becoming pregnant after ART 
cycles when using donor eggs, this study shows that the 
environment in the uterus may be compromised. If using 
their own eggs, the environment of the follicles may be 
compromised, indirectly effecting the development of the 
oocyte (Paczkowski et al., 2015). 
Overall, AMA in mice changes methylation patterns of 
imprinted genes in reproductive tissue, which results in 
dysregulated gene expression associated with poor re-
productive outcomes. This study is significant in that it 
suggests a possibility that the same factors in aged human 
females might cause negative outcomes in their pregnan-
cies as well (Paczkowski et al., 2015).  
A study was done where associations of maternal age 
at childbearing with gestational age (number of weeks 
fetus was in the womb) and fetal growth (birthweight 
adjusted for gestational age) were examined. Those fea-
tures are important to study because these problems 
predict mortality and morbidity across the lifespan of 
the human, including psychological, health, academic, so-
cial, and economic difficulties. Preterm birth is associated 
with decreased cognitive functioning in childhood and the 
use of psychiatric medications in adults. Poor fetal growth 
has been found to be linked to psychiatric diagnoses in 
childhood (autism and ADHD) and adult health problems 
(cardiovascular disease and diabetes). Given these major 
health concerns, it is imperative to obtain a better under-
standing of the possible causes of these adverse perinatal 
outcomes (Sujan et al., 2016).
The study was designed in such a way as to rule out 
genetic and environmental factors that might contribute 
to the results. To assess potential familial confounding, 
two genetically informed designs were used comparing 
cousins and siblings. To be able to generalize results, data 
was taken from two samples with different cultures, races, 
ethnicities, economic backgrounds, and healthcare cov-
erage. Some covariates were offspring birth order, and 
parental characteristics such as levels of education, his-
tory of severe psychiatric problems, history of substance 
abuse, household income, maternal race, and maternal 
age at first childbirth (Sujan et al., 2016).
There was strong evidence that AMA at childbirth was 
associated with a shorter gestational age. The gestational 
age of offspring born to 30-34 year old mothers, 35-39 
year old mothers, and mothers of 40 years and above, 
were all less than the gestational age of offspring born to 
25-29 year old mothers. Even after accounting for shared 
familial factors, the data pointed to a strong link between 
mothers who are older at childbirth with shorter gesta-
tional age. This did not hold true for lower fetal growth. 
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Results from the study supported a causal association 
between AMA at childbearing and shorter gestational age 
(Sujan et al., 2016).
Further research is needed to explore specific factors 
that might account for the findings. Some possibilities 
might be maternal diseases, such as hypertension, diabe-
tes, and the quantity of oxygen and nutrients received 
during the prenatal period (Sujan et al., 2016). 
Another study tested the hypothesis that reduced fetal 
weight and lower success of pregnancy outcomes in AMA 
rats may be attributed to sex-specific changes in the mor-
phological development of the placenta and in its nutrient 
transport function. It was found that the sex of the fetus 
did indeed influence the placenta and offspring outcome 
in response to the adverse environment in the uterus 
during gestation (Napso et al., 2019).
Young (3-4 months old) and aged (9.5-10 months old) 
Sprague Dawley female rats were mated with young male 
Sprague Dawley rats (3-5 months old) and were evalu-
ated on gestational day 20. The study demonstrated that 
advanced maternal age caused modifications in the phe-
notype of the placenta and in this way, altered its ability 
to support the growth of a fetus. In particular, it modified 
the expression of genes and proteins that are crucially 
important in placental growth, transfer of nutrients, en-
docrine control of maternal physiology, and control of 
exposure of the fetus to glucocorticoids. AMA causes ox-
idative stress and cell death in the placenta, in a manner 
that is partially dependent on the sex of the fetus. The 
study also indicated that gene expression changes in the 
placenta of female fetuses were mostly beneficial, with 
an up-regulation of genes that support the function of 
the placenta. Gene expression changes in the placenta of 
male fetuses, though, were mostly detrimental for placen-
tal growth and functional phenotype in older rats. There 
was similar growth restriction in both male and female 
fetuses, although the absolute weight of male fetal heart, 
brain, and liver were more reduced in fetuses of aged rats 
than younger ones (Napso et al., 2019). There were pre-
vious studies that demonstrated poorer cardiovascular 
outcomes for adult male rats born from aged mothers 
(Shah et al., 2018 as cited in Napso et al., 2019). 
The sex-dependent changes in glucocorticoid handling 
in the placenta of AMA mothers affects health outcomes 
of offspring later in life. Elevated prenatal exposure to 
glucocorticoids affects development of the fetus and per-
manently alters the structure and functions of its organs, 
predisposing the offspring to certain diseases later in life 
such as hypertension (Napso et al., 2019). Even though 
the fetal weight for male and female fetuses of aged rats 
was compromised similarly, studies showed that adult 
male offspring of aged rats have a greater chance of devel-
oping cardiovascular dysfunction as adults, as compared 
to female offspring (Shah et al., 2018 as cited in Napso 
et al., 2019). 
In summary, AMA affects the phenotype of the rat pla-
centa in a sex-dependent manner. In female fetuses from 
aged rats, there were larger beneficial changes in structure 
and/or expression of genes related to placental transport 
of nutrients from mother to fetus and improved handling 
of glucocorticoids. In male fetuses of aged rats, there 
were no beneficial changes in the transport system and 
there was less protection from glucocorticoids, greater 
oxidative stress, and elevated levels of apoptosis. These 
sex-dependent changes in placental response to the envi-
ronment in the uterus of the aged mother play a role in 
the future health of female and male offspring. The results 
of this study have implications for managing human preg-
nancies, especially in developed countries where women 
are becoming pregnant at an older age. Targeted inter-
ventions can be developed to improve placental develop-
ment and function which, in turn, will aid fetal growth and 
development for mothers of AMA (Napso et al., 2019). 
Although women of AMA are a growing population 
in all developed countries with greater obstetric risks, 
women who live in the Mediterranean have specific char-
acteristics that are different than other areas. A study 
was done to establish an AMA cut-off age in a selected 
Mediterranean population in Barcelona. Although most 
studies define AMA as being above 35 years, this study 
defined AMA in Spain as being above 40 years. The aver-
age age of women delivering their first baby rose from 
25.2 years in 1975 to 30.7 years in 2016. Models predict 
that by 2050, the average age of a first pregnancy will 
be 33 years. In 2016, 38.7% of deliveries in Spain were 
to mothers over 35 years, and 8.39% were to mothers 
over 40 years. The average age of women at childbirth in 
2017 was 32.5. The scientific community is interested in 
gaining information about the impact of AMA on obstet-
rical outcomes so that they can better assess risks in this 
increasing population (Nieto et al., 2019).  
The cohort in this study were women who gave birth 
between January 2007 to June 2017. A total of 25,054 
pregnancies were included. The average maternal age was 
34.7 +/- 4.2 years. In this study, 2,807 patients were be-
tween 40-44 years and 280 patients were >45 years. Of 
the total pregnancies, women above the age of 40 account-
ed for 12.3% of the deliveries. Confounding factors were 
considered, which included chronic hypertension, preges-
tational diabetes types I/II, use of ART, obesity, smoking, 
previous C-sections, and multiparity (having more than 
one child). Over 97% of the women were Caucasian and 
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99.8% were from the Mediterranean area. After adjusting 
for confounding factors, age proved to be a significant 
risk factor in developing gestational diabetes, especially in 
women >40. The risk of placenta previa increased as well 
in women >40 years. Preeclampsia and prolonged hospi-
talization were only associated with women >45 years. 
The risk of these negative outcomes increased as the age 
of the women increased (Nieto et al., 2019).  
It was suggested that the reason for the increased risk 
of gestational diabetes in women >40 might be endotheli-
al damage. Age is known to be a cardiovascular risk factor 
that produces structural and functional changes in the 
vascular system. Dysfunctional endothelium increases the 
risk of developing insulin resistance, which then increases 
the risk of hypertension, type II diabetes, and other met-
abolic syndromes (Nieto et al., 2019).  
In summary, in this study, women >40 were the most 
positively associated with complications of gestational di-
abetes, placental previa, caesarian delivery, and prolonged 
hospitalization. They were the ones with the highest clin-
ical risks. These patients were also at greatest risk for 
iatrogenia (effects from medical interventions) since they 
have high elective C-section rates. Future investigations 
should therefore address medical interventions and preg-
nancy surveillance to improve outcomes in AMA patients 
(Nieto et al., 2019).  
Another cross-sectional study tested the hypothesis 
that there is an association between AMA and maternal 
and neonatal morbidity. The study was based on data 
obtained from 3,315 births. It compared the births of 
women who were 35 years and older, with a reference 
group of women between the ages 24-27 (Casteleiro et 
al., 2019).
Results of the study confirmed the hypothesis. Repeated 
spontaneous abortions were 2.2 times more frequent 
in the older age group compared to the younger refer-
ence group. There was a greater incidence of gestation-
al diabetes in AMA women, particularly in primiparous 
women where the risk was eight times more prevalent. 
The possibility of giving birth with the help of instruments 
was multiplied by 1.6 and the possibility of a cesarean 
delivery was multiplied by 1.5 in both primiparous and 
multiparous AMA women. Lastly, there were correlations 
between preeclampsia, preterm birth (<37 weeks) and 
low birthweight in the older age group, although the num-
bers were not high enough to have statistical significance 
(Casteleiro et al., 2019).
The cause of repeated abortions in AMA women may 
be attributed to alterations in the chromosomes, which 
increase along with increasing maternal age. The cause 
of gestational diabetes is being continually researched. 
One theory is that diabetogenic hormones, such as the 
growth hormone that releases corticotropin, produce an 
increased insulin resistance which AMA women are not 
able to overcome (Casteleiro et al., 2019).
A study was done to ascertain the effect of advanced 
maternal age on singleton pregnancies in nulliparous 
women. Records of obstetric patients were reviewed 
from routine fetal ultrasonograms that were taken in 
the middle trimester of pregnancy. Three groups were 
included in this study: a control group of ages 18-34 years 
old, advanced maternal age women of 35-39 years, and 
very advanced maternal age women over 40 years of age. 
Altogether, 957 women met the criteria to be included in 
the study (Kahveci et al., 2018).
The study clearly demonstrated that AMA nulliparous 
women with no previous chronic diseases (including obesi-
ty) had higher rates of adverse perinatal and neonatal out-
comes such as gestational diabetes, gestational hyperten-
sion, preeclampsia, small for gestational age, spontaneous 
late preterm delivery (between 34-37 weeks of gestation) 
and cesarean delivery. Gestational diabetes, gestational hy-
pertension and cesarean delivery rates were more com-
mon in the VAMA group compared to the AMA and young 
age group. No increased risk was found for spontaneous 
preterm delivery before 34 weeks, prolonged rupture of 
membranes, placenta previa, large for gestational age, and 
operative vaginal delivery (Kahveci et al., 2018).
It has been suggested that poor oxygen exchange may be 
a factor in the association between AMA and small for ges-
tational age. This stands to reason because when an unborn 
baby doesn’t get enough oxygen during pregnancy, its organs 
don’t grow as much as they should (Kahveci et al., 2018).
Concerning neonatal outcomes, admission to a NICU 
was more likely to occur in the AMA groups, but there 
was no major difference in APGAR scores, occurrences 
of low birth weight, and neonatal morbidity between the 
groups (Kahveci et al., 2018).  
During the last few decades, there has been a significant 
increase in the amount of pregnancies involving multiple 
fetuses due to the use of ART. Even in singleton pregnan-
cies, AMA poses a risk for more maternal and neonatal 
complications. Multiple gestation drives this risk up even 
more (Gluck et al., 2018).
A study was done with the goal of comparing obstet-
rical and neonatal outcomes between women older than 
35 years and women younger than 35 with the same type 
of twin pregnancy. Records were reviewed of all dicho-
rionic-diamniotic pregnancies (in which each fetus has 
its own placenta and amniotic sac) between 2009-2016 
where the babies were delivered after 24 weeks gesta-
tion. Pregnancies with abnormalities in the chromosomes 
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and those with fetal malformations were excluded. The 
older women were divided into two groups: age 35-39, 
and those >40. The control group consisted of women 
younger than 35. Altogether, 716 women were studied. 
The rate of in-vitro fertilization for conception was high-
er in the study groups (older women) than in the control 
group (Gluck et al., 2018).
AMA was found to be independently associated with 
cesarean section after adjustments were made for nul-
liparity, in-vitro fertilization, and hypertensive disorders. 
The rate of hypertensive disorders was significantly high-
er in women over the age of 35 (Gluck et al., 2018).
Twins born to women over 35 also tended to stay lon-
ger in the NICU than those born to the younger women. 
Other neonatal outcomes in women age 35 or older 
who were carrying twins were similar to the younger 
group (Gluck et al., 2018). 
A retrospective cohort study was done to evaluate 
whether AMA was independently associated with an in-
creased risk of childhood cancer in the offspring. There 
were three maternal age groups studied: 35-39, 40-50, 
and a control group of 20-34. A comparison was made 
between the three age groups for incidences of malignant 
morbidity in the offspring. Pregnancies lacking prenatal 
care, gestations of multiple fetuses, pregnancies originat-
ing with fertility treatments, and pregnancies with fetuses 
displaying congenital malformations were not included in 
this study. The offspring were followed up to the age of 
18 years. The three most common malignant forms of 
childhood cancer which were traced included leukemia, 
brain tumors, and lymphomas (Imterat et al., 2018).  
Theoretically, advanced maternal age might correlate 
with childhood cancers due to DNA damage and de-
creased repair pathways in oocytes of older mothers. 
Several previous studies (Ross et al., 2005 as cited in 
Imterat et al., 2018) showed a connection between AMA 
and meiosis errors leading to trisomies (particularly tri-
somy 21 or Down’s Syndrome) which are known to pre-
dispose for malignancies in childhood. Additionally, ART, 
which is increasingly used to offset infertility disorders 
in older women, is suggested as increasing the risk of 
childhood cancers such as retinoblastoma, by altering 
gene expression. Finally, changes in maternal hormones 
during pregnancy that are age-related, such as higher in-
trauterine exposure to endogenous estrogen and insulin 
growth factor-1, have been shown to help initiate cancers. 
Considering all the above hypothetical effects of AMA on 
childhood cancers, this study was important to conduct 
(Imterat et al., 2018).  
In the study, 201,738 deliveries were included. Results 
showed that advanced maternal age did not increase the 
risk of future malignancies in the offspring up to 18 years 
old. There was some association, though, between mater-
nal age and leukemia of the offspring which warrants fur-
ther investigation (Imterat et al., 2018).  However, overall, 
childhood cancer of offspring does not seem to be a 
major concern for AMA women planning to conceive. 
A study was done to investigate what effect AMA has 
separately in nulliparous and multiparous women on ob-
stetric and neonatal outcomes in singleton pregnancies. 
The study was a hospital-based analysis of 6,619 births 
between January 2004 and May 2007. AMA was defined 
as 35 years and older. Nulliparity was defined as women 
who had not delivered a viable fetus (greater than 24 
weeks of gestation in the past) and multiparity was de-
fined as women who had at least one pregnancy in the 
past that progressed beyond 24 weeks of gestation. The 
actual parity number wasn’t considered. Of the study 
participants, 42.7% were nulliparous and 57.3% were 
multiparous. Of the nulliparous, 21.8% were of advanced 
maternal age and of the multiparous, 42.1% were of ad-
vanced maternal age (Wang et al., 2011).
Among nulliparous women, AMA was associated with 
higher rates of cesarean sections both before and during 
labor, as well as vaginal deliveries assisted by instruments. 
Among multiparous women, however, AMA was only as-
sociated with a higher rate of cesarean sections before 
labor. This might be due to a greater percentage of mul-
tiparous women requesting cesareans (Wang et al., 2011).
A study was done in order to assess how pre-pregnancy 
weight (or body mass index) and gestational weight gain 
affect pregnancy outcomes in AMA women. This retro-
spective analysis was conducted on postpartum and hos-
pital delivery data in China. A total of 1,015 women were 
included in the study who gave birth from January-June 
2017. In China, 60% of all pregnancies are in women great-
er than 35 years of age and half of these women are above 
40 years of age. AMA women are often overweight before 
pregnancy and are more likely to have internal diseases. 
They are also more likely to be multiparas having had at 
least one previous child. Age is also an independent risk 
factor for adverse pregnancy outcomes (Lin et al., 2019).
The women were divided into an advanced age group 
(35-40 years) and a super advanced age group (>40 
years). Body mass indices prior to pregnancy were di-
vided into underweight, normal weight, overweight and 
obese groups. Gestational weight gain was subdivided 
into three groups (Lin et al., 2019).
Results showed that being overweight prior to preg-
nancy increases gestational diabetes mellitus, hyperten-
sive disorders complicating pregnancy, and fetal macroso-
mia where a newborn is significantly larger than average. 
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Poor weight gain during pregnancy increased the risk of 
preterm births, but excessive weight gain during pregnan-
cy increased macrosomia in the babies of AMA women 
(Lin et al., 2019).
The women in the super advanced maternal age group 
had higher incidences of both being overweight and 
obese than those in the AMA group. The super advanced 
maternal age group had more incidences as well of gesta-
tional diabetes mellitus, hypertensive disorders, and mac-
rosomia than in the advanced age group (Lin et al., 2019).
Overall, controlling weight gain both prior to and 
during pregnancy reduced adverse pregnancy outcomes 
in AMA women (Lin et al., 2019). It is good advice for 
older women who are planning to conceive to get their 
weight under control beforehand. 
A study was conducted with the objective of determin-
ing whether there was an association between AMA and 
race on pathology of the placenta in very low birthweight 
infants. A retrospective cohort analysis was done on pla-
cental pathology on very low birthweight singleton in-
fants born between July 2002 and June 2009. There were 
739 cases included in this study (de Jongh et al., 2015).  
The placenta is the area where maternal-fetal oxygen 
and nutrients get exchanged and so it has an important 
influence on birthweight and is necessary for a successful 
outcome to a pregnancy. Placental growth, which can be 
measured in terms of placental weight, is a good indica-
tor of how well the placenta is functioning. The placenta 
weight/birthweight ratio is used to indicate neonatal out-
comes (de Jongh et al., 2015). Both high and low ratios 
have been associated with an increased risk for stillborn 
and other negative neonatal outcomes (McNamara et al., 
1998 as cited in de Jongh et al., 2015). 
The subjects of the study were divided into two groups: 
maternal age <35 and maternal age >35. Mean placental 
weights, mean birthweights, and placental weight/birth-
weight ratios were calculated for each age group (de 
Jongh et al., 2015).  
In the final analysis, AMA was seen to be associated 
with a decrease in placental weight and placental weight/
birthweight ratio. AMA, and not race or ethnicity, re-
mained independently associated with placental weight/
birthweight ratio. It could not be determined, however, 
if older maternal age directly causes reduced placental 
weight/birthweight or whether it represents confounding 
variables not tested for. Further research is necessary to 
discover possible causal mechanisms that can explain the 
relationship between AMA and lower placental weights in 
very low birthweight babies (de Jongh et al., 2015).  
In Denmark, the rate of cesarean sections increased by 
49% between the years 1998-2015 and occurred in 21% 
of all births. This is a cause for concern since cesarean sec-
tions can have short and long term consequences for the 
mother and child and can present risks in future pregnancy. 
A possible cause of the increase may be the delaying of 
pregnancy until advanced maternal age. AMA at childbirth 
has been found to be linked to pre-pregnancy morbidity 
that might account for the increased risk of cesarean sec-
tion. The goal of this study that included one million Danish 
women was to examine the relationship between AMA 
and cesarean section, taking demographics, health and 
obstetric factors into the equation. There were three age 
groups (30-34, 35-39, >40 years) with a reference group of 
maternal age less than 30 (Rydahl et al., 2019).  
A positive association was found between AMA and 
cesarean section. When adjusting for confounders, there 
were only minor changes in the risk factor. When com-
pared to the reference group, nulliparous women aged 
35-39 had twice the risk of cesarean section, while women 
of 40 and above had three times the risk. For multiparous 
women, the risk was more moderate (Rydahl et al., 2019). 
Cesarean sections are one of the most intrusive 
obstetric interventions and is becoming much more 
common in industrialized countries. The increase in ce-
sarean sections is mainly a result of AMA, especially in 
nulliparous women. Morbidity tends to increase as age 
increases, so AMA women will include more individuals 
with prenatal risk factors such as hypertension, diabe-
tes mellitus, and higher body mass index than younger 
pregnant women. More women of advanced age will also 
develop pregnancy related complications, including gesta-
tional diabetes, preeclampsia and placenta previa. There is 
also evidence that there is a decline in the physical ability 
to maintain uterine contractions which can cause labor 
dystocia. Future studies on the possibility of advanced age 
affecting the ability to maintain progression of labor is 
recommended. Placenta previa in AMA women, as well as 
non-vertex fetal presentations might also necessitate a 
cesarean delivery (Rydahl et al., 2019).  
The higher cesarean section rate may be a result of 
these comorbidities related to AMA. It is possible, though, 
that the lower threshold for cesareans may be influenced 
by the attitudes of the healthcare professionals treating 
AMA women who may view them as high-risk patients or 
by the mothers themselves who choose a cesarean birth 
because they are more anxious about the health of the 
fetus (Rydahl et al., 2019).  
A study was done regarding the association between 
maternal age and offspring adult health. There is increas-
ing documentation associating AMA with negative health 
outcomes in their offspring. This association is considered 
to be a reflection of aging physiological processes of the 
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mother, such as the decreasing quality of her placenta or 
eggs (Myrskyla & Fenelon, 2012).   
In this study, the role of socioeconomic selection and 
lifespan overlap between the generations is examined, 
as they are related to the association between maternal 
age and offspring adult health. It was found that offspring 
born to mothers younger than 25 or older than 35 have 
the worst outcomes regarding health, height, obesity, 
and even mortality. The reason for the young maternal 
age-offspring health link may be due to the physiological 
immaturity and socioeconomic disadvantage of young 
parenthood. Regarding the older age group, the results of 
the study showed that negative outcomes are not due to 
the mother leaving a physiological imprint in the offspring 
that causes a predisposition to diseases in adulthood. 
Rather, maternal education (which is strongly connected 
to socioeconomic status) and the age at which the child 
loses the parent are two important factors that affect 
the correlation between AMA and offspring adult health 
(Myrskyla & Fenelon, 2012).  
Mothers of advanced age have generally had the oppor-
tunity to obtain a higher level of education which trans-
lates into greater affluence. Childhood socioeconomic 
status has been found to be strongly connected to adult 
health and mortality (Myrskyla & Fenelon, 2012).  
The age at which a child loses a parent is directly re-
lated to maternal age. If all other factors are held con-
stant, a child born to a younger mother will have many 
more years of lifespan overlap with the mother than a 
child born to an older mother. The psychological shock 
of losing a parent at a younger age is one factor that may 
affect the adult child’s health. Another factor might be the 
loss of parental involvement with the offspring. Thirdly, a 
shorter lifespan overlap might indicate a genetic frailty 
that runs in the family (Myrskyla & Fenelon, 2012).  
Maternal age, therefore, is related to the mother’s ed-
ucation, socioeconomic status, and lifespan overlap with 
the offspring, all of which were found to be confounders 
in the maternal age-offspring health association. These 
factors all help explain the mechanism behind the asso-
ciation of AMA and negative health outcomes in the off-
spring and challenge the standard interpretation for that 
association. The reason this study is important is because 
today’s parents, even if they reproduce at an older age, 
will likely live longer due to medical advances and there-
fore have a longer lifespan overlap with their offspring. 
If biological aging is indeed not the factor to influence 
the adult health of offspring but rather lifespan overlap is, 
AMA women can be reassured going forward that their 
late childbearing will not adversely affect their offspring 
(Myrskyla & Fenelon, 2012).  
In the latter half of the last century, the delay of child-
bearing in Western cultures has affected the biology of 
the mother-fetus relationship. Data obtained from exper-
iments, as well as clinical observations, have ascertained 
this change. As an example, there has been an increase in 
type 1 diabetes in developed countries during this time. 
This trend parallels the tendency to give birth at a later 
age which might suggest a causal relationship between 
the two events. Delayed childbearing might therefore 
have a detrimental effect not only on the development 
of the fetus in the uterus but may possibly be causing a 
predisposition to certain severe disorders. The change to 
the reproductive organs due to age, along with changes 
in hormone activity, may be the causes of this negative 
relationship (Gloria-Bottini et al., 2005). 
A study done in Italy might also suggest that delayed 
childbearing is causing a change in the genetic compo-
sition of the population. Gene frequency refers to the 
proportion of a population that carries one type of allele, 
or gene variation, at a particular point on a chromosome. 
Certain phenotypes either increase or decrease with ma-
ternal age. These changes in the genetic composition of 
AMA women were found to be similar in the mothers 
and newborns studied (Gloria-Bottini et al., 2005). 
The hypothesis of the study, which included over 600 
women giving birth, was that advanced maternal age may 
influence intrauterine selection by favoring genotypes that 
are best able to adapt to the intrauterine environment of 
the older mothers. Zygotes that are more resistant to the 
changes in the maternal environment of older women will 
be the ones to survive. Maternal and neonatal genotypes 
were found to be similar in the AMA women studied. 
Maternal age was, therefore, having an effect on the gene 
frequency in the offspring (Gloria-Bottini et al., 2005).
Very Advanced Maternal Age (VAMA)
In Australia, as in most other high-income countries, child-
bearing age has been rising to 35 years and above. A new 
trend is emerging of pregnancies in women even 45 years 
and older which comprise 0.1% of all births in the coun-
try and is continually rising. This is driven partly by assist-
ed reproductive technologies such as oocyte donation. 
There were few studies examining perinatal outcomes in 
this age group. A state-wide population-based study was 
done in Victoria, Australia covering the years 2005-2006 
to determine maternal health and the outcomes of preg-
nancies of women in this age group compared to women 
aged 30-34 years (Carolan et al., 2013).   
The study revealed prenatal complications of at least 
one of the following: gestational diabetes, antepartum 
hemorrhage (bleeding from or in the genital tract), 
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placenta previa, and multiple births. There was weak ev-
idence for increased risk for preeclampsia. Women >45 
were also more likely to have caesarian sections. They 
were not found to be more likely of having a postpartum 
hemorrhage (Carolan et al., 2013).   
Pre-existing medical conditions of the mothers, as well 
as parity and use of ART, were taken into account. Women 
aged 45 and older were most likely to have pre-existing 
hypertension, but there was weak evidence of pre-exist-
ing diabetes. Women in the group were 12 times more 
likely to have used ART (Carolan et al., 2013).   
Babies born to these VAMA (very advanced maternal 
age) mothers were at a higher risk for preterm birth 
(between 32-36 weeks gestation) regardless of parity, 
low birth weight (less than 2,500 grams) for primiparous 
women and had higher odds of being small for gestational 
age. Rates of preterm birth were very high for multiple 
births and for those who used ART (Carolan et al., 2013). 
The findings in this study have ramifications for 
the women as well as for their healthcare providers. 
Although results displayed higher rates of pregnancy 
and perinatal negative outcomes for the women aged 
45 and older in Victoria, Australia, nevertheless, the 
findings were reassuring as the vast majority of these 
women of very advanced age gave birth to healthy ba-
bies. The rate of perinatal death was low (less than 10 
per 1,000 births). This suggests that with good prenatal 
care, most women in this group can achieve a live birth. 
Future studies should include investigations into the fu-
ture health of these children who were preterm birth 
or were of low birth weight or small for gestational age 
(Carolan et al., 2013).   
A study was done to investigate the interplay between 
very advanced maternal age (>43 years) and assisted re-
productive technology on adverse perinatal outcomes. 
Data was taken from a cohort of women who deliv-
ered babies in Ontario, Canada between 2012-2015. In 
Canada, the number of births in women over 40 years of 
age tripled from 2005-2014. Even though fertility declines 
as a women ages, ART has allowed many more women 
of VAMA the chance to become pregnant. ART, though, 
has been considered a risk factor for adverse pregnancy 
outcomes as compared to spontaneous conceptions. This 
particular study aimed to assess the pregnancy outcomes 
of women who were both of very advanced age and who 
used ART to conceive. Singleton pregnancies of women 
>20 years who delivered at 20 weeks of gestation and 
above and whose offspring’s birthweight exceeded 500 
grams were included. The women were put into three 
categories of age: 20-34 years, 35-42 years, and >43 years 
of age. VAMA was defined as >43. All the subjects used 
were noted as either having used ART or having sponta-
neously conceived (Wu et al., 2019).  
The mothers age was the independent variable. The 
type of conception (ART or spontaneous conception) 
was the main covariate. ART conceptions included intra-
uterine insemination, intrauterine insemination with ovu-
lation induction but without in-vitro fertilization, in-vitro 
fertilization, and vaginal insemination. Many potential con-
founders for adverse maternal and neonatal outcomes 
were included, such as parity, income, education, body-
mass index, drug/alcohol use, and maternal preexisting 
health issues (Wu et al., 2019).  
Women at VAMA had a higher risk of a composite out-
come which included preeclampsia, intrauterine growth re-
tardation, stillbirth, and placental abruption than the moth-
ers in a younger age bracket. The fact that ART was used did 
not add to the adverse effect of VAMA, even though ART 
may play an independent role for adverse perinatal out-
comes. These outcomes were found in 10.41% of women 
under 35 and in 13.35% in women of VAMA. Regardless 
of the conception method, women of VAMA had a higher 
incidence of adverse outcomes (Wu et al., 2019).  
Another study was done to evaluate if the adverse preg-
nancy outcomes in women of very advanced age differed 
by parity and by conception method. According to a na-
tional perinatal database in Japan, women of VAMA giving 
birth rose to 28.1% of all births. A total of 365,417 women 
over the age of 30 were included. The women were di-
vided into four age groups: 30-34, 35-39,40-44, and >45. 
Pregnancies involving multiples, as well as fetuses with con-
genital abnormalities, were excluded (Ogawa et al., 2017).
Compared with the 30-34 year reference group, 
women aged 45 or older showed a higher risk for cesar-
ean sections, preeclampsia, placenta previa and preterm 
birth. Placental abruption, very preterm birth, low 
APGAR score and perinatal death were not seen as being 
of increased risk in VAMA. The effects of older age on the 
negative outcomes were significantly higher among those 
women who conceived naturally, compared to those who 
used ART to conceive. However, the possibility that ab-
normal embryos were removed during ART could have 
skewed the results. The effect of advanced age on cesar-
ean deliveries was stronger among primiparous women, 
but the risk for preeclampsia was significantly stronger 
among multiparous women (Ogawa et al., 2017).
The effects of advanced age on preterm birth were sig-
nificantly greater among women who conceived without 
ART than among those who used ART to conceive. To 
clarify, while the risk of preterm birth generally increased 
with age in women who conceived without ART, it de-
creased in women who conceived with ART. Therefore, 
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younger women who conceived through ART, may have a 
greater risk of preterm birth than women who are older 
and conceive through ART (Ogawa et al., 2017).
The greater risk of cesareans in primiparous women of 
advanced age may be due to higher rates of elective cesare-
an sections requested by primiparous older women. It might 
also be due to prolonged labor or compromised fetal status 
requiring emergency cesarean section with increasing age, 
but these hypotheses were not tested (Ogawa et al., 2017).
While the greater risk of preeclampsia in multiparous 
older women in this study contrasted to a previous study 
(Bianco et al., 1996 as cited in Ogawa et., 2017) which found 
no change in risk of preeclampsia in both primiparous and 
multiparous women of age, this might be explained by the 
recent use of low dose aspirin in women with a higher 
risk of preeclampsia. Since both primiparity and advanced 
age are both strong risk factors for preeclampsia, these 
women may be more likely to receive the medication than 
multiparous women (Ogawa et al., 2017).
Regardless of the way VAMA women conceive, the 
need for preconception counselling, and greater prenatal 
care in these women should be a priority. Regular pre-
natal visits and testing can help address potential con-
cerns early on and reduce the risk of pregnancy and birth 
complications which can be even more devastating, both 
emotionally and financially. 
Conclusion
Many studies have been done in various developed coun-
tries investigating what impact AMA has on perinatal 
and neonatal outcomes. The consensus is that advanced 
maternal age increases the mother’s risk for developing 
medical conditions such as cancer, diabetes, hypertension, 
and arthritis. The probability of pregnancy complications 
increases as well. Among these complications are chro-
mosome anomalies, placenta previa, placental abruption, 
caesarean birth, preterm labor and low birthweight. 
Abnormal functioning of the placenta and impairment in 
oocyte development potential, both due to aging, can re-
sult in fetal growth restriction and even stillbirth. Women 
who are of very advanced maternal age (over 40 and es-
pecially over 45 years of age) seem to be at even greater 
risk of pregnancy and perinatal difficulties, although risks 
differ by parity and conception method. 
Results of studies have been conflicting at times. The 
reason for this might be differences in homogeneity in 
study groups or failure to adjust for potential confound-
ers such as maternal diseases, obesity, assisted concep-
tion, pregnancies of multiples, and parity. Differences in 
definitions of pregnancy outcomes might also be a reason 
for incompatible conclusions. It is vital to determine if age 
effects are direct and have a causal relationship with ad-
verse outcomes or if they are indirect since other factors 
are at play. In order to accomplish this, future studies need 
to have control groups for age-dependent confounders. 
Inconclusive results concerning the ramifications of 
delayed childbirth must be resolved so that women of 
advanced age can make informed choices when deciding 
whether to bear children. 
Information regarding chromosome anomalies and 
the availability of prenatal screening tests are vital for 
any women over the age of 35 who are planning to be-
come pregnant. Those who receive positive results for a 
screening test can be sent for genetic counselling. Other 
emotionally supportive forms of help might come in the 
form of bereavement counselors, adoption services, or 
information on support groups for parents of multiples 
or for those who suffered a perinatal loss. 
Preconception care is especially important for women 
of advanced age planning a pregnancy.  Fertility concerns, 
pre-existing health conditions and risks for chromosome 
anomalies can be discussed. The importance of folic acid 
during pregnancy to decrease the risk of neural tube 
defects, reducing workplace risk and avoiding alcohol 
use and medications are all important topics to address. 
Older first-time mothers may need counselling regarding 
their transition into parenthood which may be more dif-
ficult for them as opposed to younger, first-time mothers. 
Most importantly, pregnancy surveillance in this older age 
group must be stressed in order to improve outcomes 
for both mother and baby. 
The trend of increased advanced maternal age is 
expected to continue and thus the effects of AMA on 
maternal and fetal morbidity and mortality is, and will 
be, of great concern. The unique needs of this popula-
tion must be addressed not only to benefit the mothers 
and babies themselves but for the implications that it 
has for the healthcare system and for service providers. 
Promoting the health of these women and their offspring 
and preventing negative outcomes reduces healthcare 
costs overall and will have an impact, going forward, on 
employment policies which will, hopefully, become more 
pregnancy-friendly. 
Overall, older women who are in generally good health 
can hope to have favorable outcomes to their pregnan-
cies with good prenatal care. Advanced technologies in 
perinatology have improved their chances of giving birth 
to a healthy child. If the needs for preconception counsel-
ling, targeted surveillance and early medical intervention 
are met, then there is no definite medical reason for ex-
cluding AMA women from attempting a pregnancy on the 
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